TRAUMALAB INTERNATIONAL ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  12.4% 13.4% 16.4% 13.5% 17.2%  
Credit score (0-100)  21 18 12 16 8  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6

Net sales  0 0 0 0 0  
Gross profit  -38.5 -13.6 -20.1 -1.8 0.6  
EBITDA  -38.5 -13.6 -20.1 -1.8 0.6  
EBIT  -38.5 -13.6 -20.1 -1.8 0.6  
Pre-tax profit (PTP)  -38.6 -13.6 -21.5 -3.5 0.6  
Net earnings  -30.1 -10.6 -35.8 -3.5 0.6  
Pre-tax profit without non-rec. items  -38.6 -13.6 -21.5 -3.5 0.6  

 
See the entire income statement

Balance sheet (kDKK) 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  20.9 10.3 -25.5 -29.1 -28.5  
Interest-bearing liabilities  11.0 11.0 15.0 29.3 28.4  
Balance sheet total (assets)  39.9 27.2 2.6 0.2 0.0  

Net Debt  -5.2 6.8 15.0 29.3 28.4  
 
See the entire balance sheet

Volume 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -38.5 -13.6 -20.1 -1.8 0.6  
Gross profit growth  -169.4% 64.7% -48.0% 90.9% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  40 27 3 0 0  
Balance sheet change%  -42.1% -31.9% -90.6% -92.3% -100.0%  
Added value  -38.5 -13.6 -20.1 -1.8 0.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 -3.0 -4.0 -5.0 1.0  

Profitability 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -70.8% -40.5% -72.9% -6.4% 2.2%  
ROI %  -81.3% -51.2% -111.0% -8.3% 2.2%  
ROE %  -83.7% -68.1% -558.3% -257.0% 633.5%  

Solidity 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Equity ratio %  52.3% 37.8% -90.9% -99.3% -100.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  13.5% -49.6% -74.4% -1,592.5% 4,718.1%  
Gearing %  52.6% 107.0% -58.7% -100.7% -100.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.3% 0.0% 10.1% 7.7% 0.0%  

Liquidity 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Quick Ratio  1.6 1.1 0.1 0.0 0.0  
Current Ratio  2.1 1.6 0.1 0.0 0.0  
Cash and cash equivalent  16.2 4.2 0.0 0.0 0.0  

Capital use efficiency 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  20.9 10.3 -25.5 -29.1 -28.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0